Cargando…

Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease

Metabolic associated fatty liver disease (MAFLD) is a multifactorial systemic disorder that occurs in the absence of excessive alcohol consumption. The disease is characterized by fatty degeneration and fat accumulation in liver parenchymal cells, the incidence of which is increasing annually, parti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Tingting, Yu, Liping, Zhuang, Rangxiao, Xi, Jianjun, He, Ruoyu, Shao, Yidan, Huang, Jinsong, Liu, Shourong, Yang, Xingxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221858/ https://www.ncbi.nlm.nih.gov/pubmed/34222135 http://dx.doi.org/10.1155/2021/5527315

Ejemplares similares

Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis
por: Shi, Tingting, et al.
Publicado: (2018)

Protective effect of apigenin magnesium complex on H(2)O(2)-induced oxidative stress and inflammatory responses in rat hepatic stellate cells
por: Pan, Xuwang, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine
por: Shi, Tingting, et al.
Publicado: (2020)

Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer
por: Cao, Yu, et al.
Publicado: (2020)

Protective effect of N-acetylcysteine activated carbon release microcapsule on myocardial ischemia-reperfusion injury in rats
por: Cai, Zhaobin, et al.
Publicado: (2018)

Protective effects of N-acetylcysteine on cisplatin-induced oxidative stress and DNA damage in HepG2 cells
por: WANG, FUGEN, et al.
Publicado: (2014)

Effects of activated carbon N-acetylcysteine sustained-release microcapsule on dipeptidyl peptidase IV expression in young rats with non-alcoholic fatty liver disease
por: Zhou, Hongping, et al.
Publicado: (2017)

Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
por: Xu, Jingqi, et al.
Publicado: (2021)

Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
por: Chen, Qian, et al.
Publicado: (2017)

Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
por: Colca, Jerry R., et al.
Publicado: (2017)

Mitochondrial DNA methylation in metabolic associated fatty liver disease
por: Mposhi, Archibold, et al.
Publicado: (2023)

Mitochondrial folate metabolism–mediated α-linolenic acid exhaustion masks liver fibrosis resolution
por: Gao, Yanjie, et al.
Publicado: (2023)

Volatile Oil of Amomum villosum Inhibits Nonalcoholic Fatty Liver Disease via the Gut-Liver Axis
por: Lu, Shanhong, et al.
Publicado: (2018)

Traditional Chinese medicines and natural products targeting immune cells in the treatment of metabolic-related fatty liver disease
por: Li, Zhen, et al.
Publicado: (2023)

Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice
por: Yao, Zheng, et al.
Publicado: (2023)

Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis
por: Yang, Jie, et al.
Publicado: (2022)

Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease
por: Stec, David E., et al.
Publicado: (2020)

Editorial: Natural products as potential therapies for non-alcoholic fatty liver disease
por: Ibrahim, Islam A. A. E. H., et al.
Publicado: (2023)

Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
por: Goedeke, Leigh, et al.
Publicado: (2021)

Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
por: Cheng, Yuan-Lung, et al.
Publicado: (2017)

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy
por: Ramanathan, Raghu, et al.
Publicado: (2022)

The multifaceted roles of natural products in mitochondrial dysfunction
por: Chen, Qianrun, et al.
Publicado: (2023)

Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability
por: Hoene, Miriam, et al.
Publicado: (2021)

Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction-associated fatty liver disease in mice
por: Scalcon, Valeria, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
por: Guo, Xiangyu, et al.
Publicado: (2022)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Editorial: Nanotechnology for natural products
por: Du, Jingshan S., et al.
Publicado: (2022)

Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models
por: Zhao, Qiong-Ya, et al.
Publicado: (2020)

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2020)

Therapeutic developments in metabolic dysfunction-associated fatty liver disease
por: Shi, Yiwen, et al.
Publicado: (2022)

The Metabolically Benign and Malignant Fatty Liver
por: Stefan, Norbert, et al.
Publicado: (2011)

Prevalence of fatty liver in metabolic syndrome
por: Goyal, Anita, et al.
Publicado: (2020)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver
por: Zobeiri, Mehdi, et al.
Publicado: (2021)

Influence of Polysaccharides From Polygonatum kingianum on Short-Chain Fatty Acid Production and Quorum Sensing in Lactobacillus faecis
por: Yang, Min, et al.
Publicado: (2021)

Diagnostic ability using fatty liver and metabolic markers for metabolic‐associated fatty liver disease stratified by metabolic/glycemic abnormalities
por: Okada, Akira, et al.
Publicado: (2022)

Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
por: Xu, Haiyun, et al.
Publicado: (2019)

Altered Metabolic Flexibility in Inherited Metabolic Diseases of Mitochondrial Fatty Acid Metabolism
por: Tucci, Sara, et al.
Publicado: (2021)

Metabolic-associated fatty liver disease and lipoprotein metabolism
por: Heeren, Joerg, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_10od5mjvbb3lj7ivk8q9q3t0mv